These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 23207876

  • 1. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 2. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial.
    Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C.
    Nephrol Dial Transplant; 2011 Aug; 26(8):2521-6. PubMed ID: 21285125
    [Abstract] [Full Text] [Related]

  • 4. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
    Caletti MG, Balestracci A, Missoni M, Vezzani C.
    Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
    Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L.
    Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, controlled study of losartan in children with proteinuria.
    Webb NJ, Lam C, Loeys T, Shahinfar S, Strehlau J, Wells TG, Santoro E, Manas D, Gleim GW.
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):417-24. PubMed ID: 20089489
    [Abstract] [Full Text] [Related]

  • 7. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R.
    N Engl J Med; 2009 Jul 02; 361(1):40-51. PubMed ID: 19571282
    [Abstract] [Full Text] [Related]

  • 8. Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).
    Fried LF, Duckworth W, Zhang JH, O'Connor T, Brophy M, Emanuele N, Huang GD, McCullough PA, Palevsky PM, Seliger S, Warren SR, Peduzzi P, VA NEPHRON-D Investigators.
    Clin J Am Soc Nephrol; 2009 Feb 02; 4(2):361-8. PubMed ID: 19118120
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion.
    Adler L, Mathew R, Futterweit S, Frank R, Gauthier BG, Kashtan CE, Trachtman H.
    BMC Nephrol; 2002 Feb 14; 3():2. PubMed ID: 11869456
    [Abstract] [Full Text] [Related]

  • 10. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Feb 14; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 11. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
    He YM, Feng L, Huo DM, Yang ZH, Liao YH.
    Nephrology (Carlton); 2013 Sep 14; 18(9):605-14. PubMed ID: 23869492
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.
    Kou J, Wu J, Yang HT, He YN, Fang JA, Deng YY, Xie YS, Nie LF, Lin HL, Cai GY, Chen XM.
    Trials; 2014 Dec 05; 15():479. PubMed ID: 25480673
    [Abstract] [Full Text] [Related]

  • 13. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 Dec 05; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 14. Alport syndrome: the effects of spironolactone on proteinuria and urinary TGF-β1.
    Giani M, Mastrangelo A, Villa R, Turolo S, Marra G, Tirelli AS, Hopfer H, Edefonti A.
    Pediatr Nephrol; 2013 Sep 05; 28(9):1837-42. PubMed ID: 23748277
    [Abstract] [Full Text] [Related]

  • 15. Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.
    Caletti MG, Missoni M, Vezzani C, Grignoli M, Piantanida JJ, Repetto HA, Exeni R, Rasse SM.
    Pediatr Nephrol; 2011 Aug 05; 26(8):1247-54. PubMed ID: 21533629
    [Abstract] [Full Text] [Related]

  • 16. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 05; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 17. Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.
    Bryant CE, Rajai A, Webb NJA, Hogg RJ.
    Pediatr Nephrol; 2021 Oct 05; 36(10):3211-3219. PubMed ID: 33881639
    [Abstract] [Full Text] [Related]

  • 18. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
    Sakallı H, Baskın E, Bayrakcı US, Moray G, Haberal M.
    Exp Clin Transplant; 2014 Aug 05; 12(4):310-3. PubMed ID: 24447308
    [Abstract] [Full Text] [Related]

  • 19. Enalapril in paediatric patients with Alport syndrome: 2 years' experience.
    Proesmans W, Knockaert H, Trouet D.
    Eur J Pediatr; 2000 Jun 05; 159(6):430-3. PubMed ID: 10867848
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA, Calzada C, Ballesteros A, Amato D.
    Rev Invest Clin; 2012 Jun 05; 64(4):315-21. PubMed ID: 23227581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.